<!DOCTYPE html>
<html lang="bn">
  <head>
    <meta charset="UTF-8">
    <title>Volibo - Indication, Positioning & USPs</title>
<style>
        body {
            font-family: 'Segoe UI', sans-serif;
            background-color: #f8f9fa;
            padding: 20px;
            color: #222;
        }
        .container {
            max-width: 850px;
            margin: auto;
            background: #fff;
            padding: 30px;
            border-radius: 10px;
            box-shadow: 0 5px 12px rgba(0,0,0,0.1);
        }
        h2 {
            color: #0074b7;
            border-bottom: 2px solid #eee;
            padding-bottom: 6px;
        }
		h1 {
      background-color: #0D9A9F;
      color: white;
      padding: 14px;
      text-align: center;
      border-radius: 8px;
      margin-bottom: 20px;
    }
        ul {
            margin-left: 20px;
            line-height: 1.8;
        }
        .section {
            margin-top: 30px;
        }
        .footer {
            margin-top: 30px;
            color: #555;
            font-style: italic;
        }
</style>
  </head>
  <body>
    <div class="container">
	  <h1>Volibo</h1>

	  <div class="section">
		<h2>üìå Indication</h2>
		<ul>
		  <li>In the treatment of Type 2 Diabetes Mellitus:
			<ul>
			  <li>As monotherapy</li>
			  <li>In combination with other OHAs</li>
			  <li>In addition to insulin in DM Patients</li>
			</ul>
		  </li>
		  <li>In patients with persistent post prandial hyperglycemia</li>
		  <li>For preventing diabetes or delaying the conversion of pre-diabetes to diabetes</li>
		</ul>
	  </div>

	  <div class="section">
		<h2>üéØ Positioning</h2>
		<p><strong>To reduce PPHG</strong> (Post Prandial Hyperglycemia)</p>
	  </div>

	  <div class="section">
		<h2>‚≠ê Highlighting Points / USPs</h2>
		<ul>
		  <li>Suitable for patients with early type 2 diabetes / IGT</li>
		  <li>Obese diabetic patients</li>
		  <li>Elderly diabetic patients</li>
		  <li>Diabetic patients with hepatic dysfunction</li>
		  <li>Diabetic patients with mild to moderate renal impairment</li>
		</ul>
		<p><strong>Volibo prevents diabetes or delays the conversion of pre-diabetics to diabetes.</strong></p>
	  </div>

	 
    </div>
  </body>
</html>
